Survival in patients with metastatic spinal cord compression from prostate cancer is associated with the number of extra-spinal organs involved

Anticancer Res. 2013 Oct;33(10):4505-7.

Abstract

Background/aim: To investigate the predictive value of the number of extra-spinal organs involved by metastases for survival in metastatic spinal cord compression (MSCC) from prostate cancer.

Patients and methods: In 95 patients irradiated with 10 × 3 Gy for MSCC from prostate cancer, seven factors were investigated: Age, performance score, number of involved vertebrae, interval from prostate cancer diagnosis to MSCC, pre-radiotherapy ambulatory status, time to motor deficits development, number of involved extra-spinal organs.

Results: Six-month survival rates for 0, 1 and ≥ 2 involved extra-spinal organs, were 81, 53 and 33%, respectively (p<0.001). On multivariate analysis, the number of involved extra-spinal organs maintained significance (risk ratio 1.88, p=0.023). Better performance score (p<0.001), longer interval from prostate cancer diagnosis to radiotherapy of MSCC (p<0.001), and being ambulatory prior to radiotherapy (p=0.001) were also positively associated with survival.

Conclusion: The number of extra-spinal organs involved by metastases predicts survival in patients with MSCC from prostate cancer.

Keywords: Prostate cancer; extra-spinal organs; irradiation; metastatic spinal cord compression; prognosis; survival.

MeSH terms

  • Aged
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Multivariate Analysis
  • Proportional Hazards Models
  • Prostatic Neoplasms / mortality*
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy
  • Retrospective Studies
  • Severity of Illness Index
  • Spinal Cord Compression / etiology
  • Spinal Cord Compression / mortality*
  • Spinal Cord Compression / radiotherapy
  • Spinal Neoplasms / mortality*
  • Spinal Neoplasms / radiotherapy
  • Spinal Neoplasms / secondary